Cognizant's shared investigator platform grows to more than a quarter million users globally

Digital platform is helping accelerate drug discovery and influence improved healthcare by modernizing clinical trials teaneck, n.j. , sept. 20, 2022 /prnewswire/ -- cognizant (nasdaq: ctsh) announced that its shared investigator platform (sip), a life sciences software as a service (saas) solution that streamlines clinical trials to improve the speed of pharmaceutical drug discovery, has surpassed 250,000 users across 100 countries worldwide.
CTSH Ratings Summary
CTSH Quant Ranking